Today’s investment in ID research; public health and prevention; and development of new drugs, vaccines and diagnostics will pay significant dividends in the future. Such investments can prevent needless deaths, dramatically reduce health care costs, and improve the quality of life for millions of Americans and others around the world. IDSA supports appropriate funding for domestic and international programs including those at the:
- National Institute for Allergies and Infectious Diseases
- Centers for Disease Control and Prevention
- Food and Drug Administration
- Health Resources Services Administration
- U.S. Agency for International Development
- National Institute of Health’s Fogarty International Center
IDSA’s funding priorities include antimicrobial resistance; immunizations; drug, vaccine and diagnostics development; and HIV/AIDS and tuberculosis prevention and treatment.
IDSA Testimony on FY 2021 HHS Budget (PDF)
IDSA testimony prepared for the U.S. Senate Subcommittee on Labor-HHS-Education Appropriations on the FY2021 budget.
IDSA Testimony RE FY 2020 HHS Budget (PDF)
IDSA testimony prepared for the US Senate Subcommittee on Labor-HHS-Education Appropriations on the FY 2020 budget.
IDSA Testimony on FY 2020 HHS Budget (PDF)
IDSA testimony on FY 2020 Department of Health and Human Services (HHS) budget prepared for the U.S. House Subcommittee on Labor-HHS-Education Appropriations.
IDSA Testimony on FY19 HHS Budget (PDF)
IDSA testimony prepared for the Senate Subcommittee on Labor, Health and Human Services, Education, and Related Agencies Appropriations on its FY 2019 budget, submitted by IDSA President Dr. Paul Auwaerter.
IDSA FY19 House LHHS Testimony (PDF)
IDSA testimony on FY 2019 Department of Health and Human Services budget prepared for the US House of Representatives Subcommittee on Labor, Health and Human Services, and Education Appropriations.
IDSA Urges Congress to Continue US Leadership in Confronting Infectious Diseases (PDF)
In written testimony submitted to United States Senate Appropriations State and Foreign Operations Subcommittee prior to its June 13 review of the FY2018 White House budget proposal, IDSA President Dr. Bill Powderly urged Senators to sustain robust funding for global infectious disease security and responses.
IDSA Urges Congress to Reject White House Health, Research Cuts (PDF)
In written testimony submitted to United States Senate Appropriations Health and Human Services subcommittee, IDSA President Dr. Bill Powderly urged Senators to reject White House proposed cuts to biomedical research and public health program funding for 2018.
IDSA Testimony on FY2018 HHS Budget (PDF)
IDSA President Dr. Bill Powderly provided testimony to the House Subcommittee on Labor-HHS-Education Appropriations in support of HHS agencies and programs engaged in the prevention, detection, and treatment of infectious diseases.
IDSA Urges Congress to Support Research on ID Reimbursement (PDF)
At the request of IDSA, the Senate Appropriations Committee approved a provision in their FY 2017 spending bill for health programs that asks the Center for Medicare & Medicaid Services to examine the codes used by ID physicians to obtain reimbursement for evaluation and management services to make certain that they reflect the value provided patients.
IDSA Provides Testimony to House and Senate Spending Panels on 2017 Budget (PDF)
IDSA provided testimony to the House and Senate subcommittees that oversee spending on health programs. The statement largely focused on federal efforts to combat the Zika virus and antimicrobial resistance.
Need for Antibiotic Resistance Funding Featured in Testimony on FY 2016 (PDF)
IDSA provided testimony on 2016 funding for infectious diseases priorities to the House subcommittee that has oversight of health spending. The need for funding to implement the National Action Plan for Combating Antibiotic-Resistant Bacteria was featured in the statement.
IDSA Engages the Senate on 2016 Infectious Diseases Funding Needs (PDF)
IDSA provided testimony to the Senate panel that oversees federal spending on health programs. The statement encouraged the subcommittee to invest in areas such as antibiotic resistance, rapid diagnostics, immunizations, global health, and neglected tropical diseases.
IDSA Provides Testimony on Innovation to the Senate (PDF)
In preparation for a Senate hearing on the federal role in promoting innovation, IDSA provided testimony on the health and economic gains possible from new public health strategies, vaccines, antibiotics, and rapid diagnostics.
IDSA Provides Testimony for Senate Hearing on Ebola Funding (PDF)
IDSA provided testimony to the Senate Appropriations Committee in support of President Obama's request for emergency funds to deal with the Ebola outbreak. The Committee solicited stakeholder input ahead of a hearing to discuss the President's request.
IDSA Provides Testimony to Congress in Support of Funding for ID Priorities (PDF)
IDSA provided testimony that stressed the need for federal funding of ID priorities. The testimony--which touched on areas such as antimicrobial resistance, antibiotic and rapid diagnostic R&D, and immunizations--is the first in a series of advocacy activities that will be taken to engage Congress on the FY15 budget.
IDSA Letter to House Appropriators for FY2021
IDSA letter to House Appropriators on fully funding necessary domestic and global programs to protect public health, prevent and respond to outbreaks and other emergencies.
IDSA Letter to House and Senate Appropriators RE FY2020 Appropriations Omnibus Bill (PDF)
IDSA letter to House and Senate Committees on Appropriations on infectious diseases programs in FY2020 Appropriations Omnibus Bill.
Joint IDSA HIVMA PIDS Letter to LHHS Appropriators on Opioids (PDF)
Joint IDSA HIVMA PIDS letter to Senate and House Subcommittee on Labor, Health and Human Services, Education, and Related Agencies leadership on the need to consider recent legislation advanced by the Senate HELP and House E&C Committees on the opioid epidemic and infectious diseases impacts, and to provide the resources and guidance necessary to address this issue.
IDSA Letter to Congressional Leaders on Tax Reform Legislation (PDF)
IDSA urged Congressional leaders to oppose the clause in the tax reform legislation treating waived tuition as taxable income for PhD students, and to express concern about the automatic cuts to Medicare and elimination of the Prevention and Public Health Fund.
IDSA Comments RE ID Programs in FY2018 Appropriations Bills (PDF)
IDSA wrote to the House and Senate Committees on Appropriations urging them to fund infectious diseases programs in the Labor-HHS-Education, State and Foreign Operations, and Agriculture-FDA appropriations bills for FY2018.
IDSA and HIVMA Letter Re 2017 Hurricane Season (PDF)
IDSA and HIVMA wrote to members of the House Energy and Commerce Committe's Subcommittee on Oversight and Investigations thanking them for scheduling the hearing “Examining HHS’s Public Health Preparedness for and Response to the 2017 Hurricane Season.” IDSA and HIVMA are concerned about the potential infectious diseases risks posed by hurricanes.
IDSA Letter to Senate RE FY2018 DoD Appropriations Legislation (PDF)
IDSA urges Senate appropriators to provide continued support for the Defense Department's infectious disease research and development activities, such as the Military Infectious Disease Research Program (MIDRP) under the DoD's Defense Health Program/Research, Development, Test & Evaluation (RDTE), Joint Warfighter Medical Research Program (JWMRP), Peer Reviewed Medical Research Program (PRMRP), Congressionally Directed Medical Research Program (CDRMP), and the Center for Infectious Disease Research at the Walter Reed Army Institute of Research (WRAIR).
IDSA Letter to House on FY2018 DoD Appropriations Bill (PDF)
IDSA letter to the full House of Representatives regarding H.R. 3219, the FY2018 Department of Defense (DoD) appropriations bill, urging support for DoD's Defense Health Program/Research Development, Test & Evaluation (RDTE), Military Infectious Disease Research Program (MIDRP), Joint Warfighter Medical Research Program (JWMRP), the Peer Reviewed Medical Research Program (PRMRP), and other infectious disease programs.
Sign On Letter to Appropriators on AR Funding in the FY18 President's Budget Request (PDF)
IDSA joins with over 60 stakeholders from across the antimicrobial resistance (AMR) landscape to urge Congressional appropriators to reject the harmful cuts proposed in the President’s Budget Request, and to instead continue the bi-partisan support for AMR work by providing the robust funding this difficult problem requires.
IDSA Urges Congress to Strongly Fund Infectious Diseases Programs (PDF)
IDSA wrote to the leadership of the Senate and House Committee on Appropriations to complete the Labor-HHS-Education and Agriculture-FDA appropriations bills for FY 2017 with strong funding levels for infectious diseases programs, and to reject funding cuts proposed by the Administration for the National Institutes of Health, Centers for Disease Control and Prevention, US Agency for International Development, and the State Department.
IDSA Leads Support for Robust Federal Public Health and Biomedical Research Workforce (PDF)
IDSA led over 150 groups in a letter to President Trump in support of a robust federal public health and biomedical research workforce.
IDSA Joins Groups in Call for Continued Focus on Zika Funding (PDF)
Several dozen national organizations, including IDSA, joined in a letter to House and Senate appropriators. The letter urged the spending panels to provide adequate funding to address the Zika virus.
IDSA Joins Call for Completion of 2017 Budget and Increase for NIH (PDF)
In a letter to President Trump and Congressional leaders, 260 groups including IDSA urged completion of the 2017 budget process and a 6.2% boost in NIH funding to $34.1 billion.
IDSA Joins Effort to Protect Prevention Fund Programs (PDF)
As Congress considers repealing the Affordable Care Act, IDSA and 332 other health groups wrote to leaders in Congress to urge that funding be maintained for prevention programs authorized by the legislation.
IDSA Supports Public Health Emergency Response and Accountability Act (PDF)
IDSA supports the bipartisan Public Health Emergency Response and Accountability Act, which would provide a necessary mechanism for the rapid and effective distribution of resources to address future public health emergencies.
IDSA Joins CDC Stakeholders in Pushing for Budget Increase (PDF)
Dozens of national health groups, including IDSA, joined letters to House and Senate appropriators to express support for an increase in the CDC budget to $7.8 billion for FY 2017. The letter also called on Congress to reject proposed cuts to specific CDC programs.
IDSA Joins Final Push on Zika Funding (PDF)
IDSA and several dozen other organizations joined in a letter to senators urging their support of a new bill to fund the Zika response. The bill provides $1.1 billion for domestic and global activities.
IDSA Letter Urges Congress to Provide 2017 Funding for ID Programs (PDF)
In a letter to leaders of the House and Senate spending committees, IDSA urged support for federal infectious diseases programs. The letter also asked appropriators to complete the funding process before the end of the year.
IDSA Joins Groups in Advocacy for 2017 NIH Funding (PDF)
IDSA and over 200 organizations joined in a letter to leaders of House and Senate spending panels to support an increase of approximately $2 billion for the National Institutes of Health for Fiscal Year 2017.
IDSA and other Health Groups Call on Congress to Negotiate a Bipartisan Zika Deal (PDF)
National stakeholders, including IDSA, wrote to leaders in Congress asking that they advance a bipartisan bill to provide funding to address Zika as soon as they return from recess in September.
IDSA Joins Plea for Emergency Zika Funding Ahead of Congressional Recess (PDF)
In a letter to House and Senate leaders, IDSA and other health groups called on Congress to advance an emergency funding bill to address Zika before the summer recess that begins in mid-July.
IDSA Joins Stakeholders in Urging House and Senate to Restart Negotiations on Zika Funding (PDF)
IDSA and 38 other health groups wrote to Congress urging that they restart negotiations on a Zika funding following House approval of a bill that redirects funding from other public health priorities. The House approved bill is likely to stall in the Senate and faces a certain veto by President Obama.
IDSA Joins Other Public Health Groups in Effort to Maintain TB Funding (PDF)
After the Senate Appropriations Committee released details of its 2017 health spending bill, IDSA joined with 15 other groups in a letter to House appropriators urging restoration of the full budget for the CDC Division of TB Elimination. The Senate bill proposes a $5 million cut to the division.
Stakeholders Call on House and Senate to Complete Zika Funding Bill (PDF)
IDSA joined with several other health groups in calling on House and Senate negotiators to provide the highest funding level possible to address the Zika virus. The groups also asked legislators to provide new resources as opposed to repurposing funds from other public health properties.
IDSA and HIVMA Call on Leaders in Congress to Reject Attempt to Limit Defense Medical Research (PDF)
IDSA and HIVMA wrote to leaders in the Senate asking that they approve amendments to a defense bill to maintain funding for medical research. The existing language in the bill would have limited medical research conducted by the DoD, excluding work on certain infectious diseases and other conditions.
IDSA Joins Other Health Groups in Promoting Funding to Address Zika (PDF)
Over 50 health groups, including IDSA's wrote to senators urging the strongest funding possible for federal efforts to address the Zika virus before the onsset of mosquito season in much of the United States.
IDSA Joins More than 160 Groups in Supporting Senate Push for Mandatory NIH Funding (PDF)
In a letter organized by Research!America, IDSA and over 160 other groups asked leaders of the Senate's health committee to add mandatory funding for the National Institutes of Health to a biomedical innovations package that has been moving through the panel over the last three months.
IDSA Joins Groups in Advocating for Zika Funding (PDF)
IDSA and 66 other groups joined a letter to leaders in Congress, organized by the March of Dimes, in support of the administration's $1.9 billion emergency spending request to address Zika.
Nearly 50 Groups Join IDSA in Call for Sustained Investments in Federal AR Efforts (PDF)
IDSA and 47 other groups joined in a letter to House and Senate appropriators urging continued funding for programs within the Department of Health and Human Services that are a part of the National Action Plan for Combating Antibiotic-Resistant Bacteria.
Retailers Join IDSA and Pew in Push for Funding to Examine Antibiotics in Agriculture (PDF)
Major retailers, such as Walmart and McDonald's, joined with IDSA and the Pew Charitable Trusts in a letter to leaders of the House and Senate Subcommittees on Agriculture Appropriations seeking funding for efforts at the FDA and USDA to look at the use of medically important antibiotics in food-producing animals.
IDSA Joins Advocacy Effort in Support of USDA Funding to Combat Antibiotic Resistance (PDF)
IDSA joined 30 other groups in a letter to House and Senate appropriators urging FY 2017 funding of U.S. Department of Agriculture activities that address antibiotic resistance.
IDSA Joins Groups in Pushing for Strong 2017 CDC Budget (PDF)
Nearly one hundred groups, including IDSA, joined in a letter to House and Senate appropriators using a budget of $7.8 billion in fiscal year (FY) 2017 for the Centers for Disease Control and Prevention. The requested figure represents an 8% increase over FY 2016.
IDSA Joins Health Groups in Supporting Zika Funding Request (PDF)
Over 50 health groups, including IDSA, joined in a letter urging leaders of the House and Senate spending panels to approve the Administration's request for $1.9 billion to prepare for and respond to the Zika virus.
IDSA Joins Health Groups in Thanking Congress for FY16 NIH Increase (PDF)
Over 300 health groups, including IDSA, wrote a letter to House and Senate appropriators expressing thanks for the $2 billion increase provided the National Institutes of Health for FY 2016.
IDSA Joins Other Public Health Stakeholders in Seeking a CDC Budget Increase (PDF)
Over 100 groups, including IDSA, joined a letter to House and Senate appropriators asking that the CDC Budget be increased to $7.8 billion to protect public health.
IDSA and Pew Call on Health Spending Panel Leaders to Fund Antibiotic Resistance Proposals (PDF)
IDSA and the Pew Charitable Trusts wrote to leaders of the House and Senate subcommittees charged with appropriating funding for health agencies to fully fund the President's plan to combat antibiotic resistance.
IDSA Leads Stakeholder Letter Urging a Budget Compromise and Increased Appropriations (PDF)
IDSA was joined by 42 other organizations in a letter to House and Senate appropriators that urged support for a budget compromise and increased appropriations for activities to address antimicrobial resistance.
IDSA Joins Call for Food Safety Funding (PDF)
Twenty groups joined in a letter to House and Senate appropriators that called for sufficient funding to fully implement the FDA Food and Safety Modernization Act (FSMA), which strengthens and modernizes regulatory, administrative, and information-technology systems.
IDSA President Calls on Policymakers to Protect the Prevention and Public Health Fund (PDF)
Dr. Johan Bakken joined leaders from more than 60 other organizations in a letter to President Obama asking that any budget agreement developed with Congress include continued support for the Prevention and Public Health Fund. The Prevention Fund, established by the Affordable Care Act, provides much needed support for a host of programs, including Section 317 immunizations and Epidemiology and Laboratory Capacity Grants.
IDSA Joins Groups in Effort to Retain HHS Extramural Salary Cap (PDF)
IDSA joined 174 other groups in a letter to House and Senate Appropriations Committee leaders asking that the Health and Human Services extramural researcher salary cap be maintained at Executive Level II instead of reduced as proposed in the House.
Groups Ask Leaders of Congressional Spending Panels to Increase Investments in Public Health Preparedness (PDF)
IDSA joined several other health groups in letters to leaders of the House and Senate panels that oversee health spending urging that programs critical to public health preparedness be provided additional support in the FY 2016 appropriations process.
IDSA Joins Groups in Highlighting Importance of Federal Employee Participation in Scientific Conferences (PDF)
IDSA joined 83 other groups in a letter to Senate appropriators expressing thanks for their recognition of the importance of federally employed scientist being able to attend mission-relevant scientific and technical conferences.
Stakeholder Groups Share Recommendations on Global and Domestic TB Funding (PDF)
IDSA joined several other health groups in a letter urging the White House Office of Management and Budget to place high priority on funding for global and domestic tuberculosis programs as the Fiscal Year 2017 President's budget request is prepared.
IDSA Joins Health Groups in Expressing Support for Proposed NIH Innovation Fund (PDF)
IDSA joined 186 other groups in expressing support for a $10 billion National Institutes of Health Innovation Fund, as included in the House Energy & Commerce Committee's 21st Century Cures bill. The fund would provide extra support for key areas, including infectious diseases.
IDSA Helps Promote Funding for CDC Antibiotic Resistance Programs (PDF)
IDSA joined 53 other health groups in highlighting the need for increased funding for Centers for Disease Control and Prevention programs that address antibiotic resistance. The programs are all critical components of the National Strategy for Combating Antibiotic-Resistant Bacteria.
IDSA Engages Senate Finance Committee on Incentives to Spur R&D for New Antibiotics and Diagnostics (PDF)
IDSA wrote to the co-chairs of the Senate Finance Committee's new working group on business tax policy to urge consideration of incentives, such as permanent tax credits, to spur research and development for new antibiotics and rapid infectious diseases diagnostics.
IDSA Joins 75 Organizations in Promoting Investments in CDC (PDF)
IDSA joined with other members of the CDC Coalition to urge Congress to provide $7.8 billion in FY 2016 for the Centers for Disease Control and Prevention. The recommended funding level would support efforts to address antibiotic resistance and promote global health along with a host of other ID priorities.
IDSA Joins Coalition Effort to Promote Funding for Preparedness (PDF)
The Informal Coalition on Biodefense and Public Health Preparedness, which includes IDSA, wrote to appropriators seeking 2016 funding for programs critical to the nation's preparedness for natural and man-made public health threats.
IDSA Spearheads Advocacy Effort for Funding to Address Antimicrobial Resistance (PDF)
IDSA was joined by 56 groups in a letter to congressional appropriators that called for full funding of programs put forward to address antimicrobial resistance. Earlier in the year, President Obama proposed doubling the federal investment to address AR to $1.2 billion spread across CDC, NIH, and other agencies.
IDSA Joins Groups to Promote Funding for Food Safety (PDF)
IDSA joined other stakeholder groups in calling for funding to fully implement the FDA Food Safety Modernization Act (FSMA), which strengthens and modernizes the regulatory, administrative, and information technology systems that are important to the safety of the food supply.
IDSA Joins 2,100 Groups in Calling for Sequestration Relief (PDF)
As the FY 2016 budget process gets underway on Capitol Hill, IDSA and 2,100 other groups joined in a letter urging Congress to find a replacement for sequestration and avoid making deeper cuts to the non-defense discretionary (NDD) budget. The NDD budget funds many agencies important to the infectious diseases community such as NIH and CDC.
IDSA Joins Groups in Calling Attention to Innovation Deficit (PDF)
IDSA joined 132 other organizations from the health, science, higher education, and business communities in a letter to Congress urging finalization of the FY 2015 appropriations bills in order to avoid exacerbating the nation's innovation deficit.
IDSA Leads 55 Organizations in Effort to Support Funding for Antibiotic Resistance Initiatives (PDF)
IDSA was joined by 55 other organizations in a letter to the White House Office of Management and Budget (OMB) in support of new funding to address antibiotic resistance as called for by the President's Council of Advisors on Science and Technology.
IDSA Joins in Advocacy for Implementation of Food Safety Modernization Act (PDF)
IDSA and fifteen other public health groups joined in a letter to House and Senate appropriators that urges Congress to increase the FDA budget by $50 million to fully implement the Food Safety Modernization Act (FSMA). Key components of FSMA include a focus on prevention and the creation of a comprehensive food import oversight system.
IDSA Engages White House on FY 2016 Budget (PDF)
IDSA wrote to the White House Office of Management and Budget (OMB) to highlight the need for additional resources in Fiscal Year (FY) 2016 to support the federal response to antimicrobial resistance as well as for rapid ID diagnostics R&D, immunization programs, pandemic preparedness, and global health. The FY 2016 President's Budget Request is scheduled to be released on February 2, 2015.
IDSA Joins Stakeholders in Support of NHSN and AMD Funding (PDF)
IDSA joins with thirty-one groups to call on Congress to support increased funding for the National Healthcare Safety Network (NHSN) and sustained support of Advanced Molecular Detection (AMD) in the FY15 appropriations process.
IDSA Leads Advocacy Effort for CDC AR Initiative (PDF)
IDSA is joined by twenty-six health and public health groups in a letter to House and Senate appropriators in support of full funding for the CDC Detect and Protect Against Antibiotic Resistance Initiative that was proposed for FY15.
Groups Reach out to Congress on Domestic TB Funding (PDF)
IDSA joined several other groups in a letter to Congress urging increased funding for the CDC Division of Tuberculosis Elimination in FY15. Earlier this year, funding for the CDC's national TB program was reduced to FY05 levels.
Coalition of Groups Call for Federal Funding of Preparedness Efforts (PDF)
IDSA joined sixteen other groups in a letter to Congress urging federal support for medical countermeasure development and procurement. The letter also explained the importance of increased support for public health infrastructure, which has fallen significantly in recent years.
Groups Engage Congress on Food Safety Funding
IDSA joined in a letter to Congress that highlighted the need for increased funding to support activities at FDA that promote a safer food supply. The letter details some of the health and economic costs of foodborne illnesses, as well as the need for resources to further implement the Food Safety Modernization Act of 2011.
Coalition Calls for Stronger CDC Budget (PDF)
IDSA and nearly 80 other organizations that participate in the CDC Coalition called on Congress to provide $7.8 billion for CDC in FY15. The Coalition's request represents a 14% increase; in contrast, the President has proposed a 3.5% decrease for CDC.
A Thousand Groups Call for Increased Funding of Labor, HHS, and Education Agencies (PDF)
IDSA joined 1,064 other groups in a letter urging House and Senate leaders to provide Labor, Health and Human Services, and Education agencies a top-line budget allocation equivalent to the recent high-water mark of $163.6 billion reached in FY2010.